Drug profile · INN
empagliflozin + linagliptin
GLYXAMBI
- Patents linked
- 0
- News articles
- 0
Quick answer
empagliflozin + linagliptin (GLYXAMBI) is an FDA-listed pharmaceutical active ingredient. Associated with Boehringer Ingelheim Pty Ltd.
Key facts
Frequently asked questions
What is empagliflozin + linagliptin?
empagliflozin + linagliptin (GLYXAMBI) is an FDA-listed pharmaceutical active ingredient. Associated with Boehringer Ingelheim Pty Ltd.
What is the brand name for empagliflozin + linagliptin?
GLYXAMBI is a marketed brand name for empagliflozin + linagliptin. Check FDA Drugs@FDA for the current US label holder and prescribing information.